All Posts: News Release

• Palbociclib is Safe for Women with Advanced Breast Cancer Who Have Unique Gene Alteration

  WASHINGTON (December 11, 2019) — Women who receive palbociclib (Ibrance®) to treat their advanced breast cancer and have a gene alteration that can lead to a condition known as benign ethnic neutropenia (BEN) can safely receive the drug without major concerns of developing infections associated with neutropenia, or low white blood cell counts, say Georgetown Lombardi […]

  Category: News Release Tags: breast cancer, cancer research, clinical trials, health disparities, minority health

• Remission of Follicular Lymphoma for Two-Plus Years Indicates Disease-Free Status that Could Be Lifelong

  Use of next-generation sequencing provides evidence of no detectable lymphoma in these patients. Media Contact Karen Teberkm463@georgetown.edu ATLANTA (December 8, 2019) — People with f

  Category: News Release Tags: cancer, cancer research, hematology, lymphoma

• Deeper Look at Tumor’s Genetic Mutations Challenges Current Precision Medicine Approach

  WASHINGTON (December 5, 2019) — The number of genetic mutations in cancerous tumors appears to be significantly higher than previously thought, according to a new study using an advanced technology that can detect genetic mutations present only in rare cells within tumors. The finding incorporates a new mathematical approach to calculating total unique mutations in a […]

  Category: News Release Tags: cancer, medical informatics, precision medicine

• Georgetown’s Aykut Üren Named National Academy of Inventors Fellow

  Media Contact Karen Teberkm463@georgetown.edu WASHINGTON (December 3, 2019) — The National Academy of Inventors (NAI) has named Georgetown oncology researcher and educator Aykut Üren, MD, to

  Category: News Release Tags: cancer, cancer research, faculty honors

• Nearly One-Quarter of Completed Lung Cancer Clinical Trial Results Are Not Published

  WASHINGTON (November 6, 2019) — Despite the lengthy time and money commitments that are required to conduct clinical trials, a new analysis has found that up to one-fourth of completed lung cancer clinical trial results are not published, thereby depriving patients, the research community and the public of a complete picture of the current state of […]

  Category: News Release Tags: cancer, cancer research, clinical trials, lung cancer

• Tipo Agressivo de Câncer de Mama é Influenciado pela Ação Conjunta de Genes e RNA

  Mulheres Latinas são frequentemente diagnosticadas em estágios avançados de câncer de mama do tipo triplo-negativo e podem se beneficiar de tratamentos que tem como alvo a biologia de seus tumores. WASHINGTON (22 de outubro de 2019) — Mulheres diagnosticadas com um tipo menos comum e agressivo de câncer de mama, conhecido como triplo-negativo, podem ser diferenciadas […]

  Category: News Release Tags: breast cancer, cancer, health disparities

• Aggressive Form of Breast Cancer Influenced by Dual Action of Genes and RNA

  Latina women are typically diagnosed with aggressive triple-negative breast cancer at late stages and could benefit from treatments targeted to the biology of their disease. Media Contact: Kar

  Category: News Release Tags: breast cancer, cancer, health disparities

• Virtual Review of Cancer Clinical Trial Treatment Options Quicker Than Conventional Methods

  Using virtual, cloud-based, interconnected computing techniques, researchers at Georgetown University Medical Center and colleagues dramatically reduced the time needed to assess a cancer patient’s tumor profile and suitability for clinical trials.

  Category: News Release Tags: cancer, medical informatics

• Mammography Unlikely to Benefit Older Women with Chronic Illnesses

  A new study by a group of researchers including Dejana Braithwaite, PhD, from Georgetown Lombardi indicates that regular screening mammograms are unlikely to benefit women 75 and older who have chronic illnesses.

  Category: News Release Tags: breast cancer, cancer, Ralph Lauren Center for Cancer Prevention

• Georgetown Tobacco Control Expert Outlines Motivations of Altria-Juul Deal and Its Public Health Impact

  In a new journal article, David Levy, PhD, professor of oncology at Georgetown Lombardi Comprehensive Cancer Center, and colleagues explore the motivations of both parties in Altria’s purchase of Juul Labs

  Category: News Release Tags: cancer, vaping